Disease Mongering (Pseudo-Disease Promotion)
Indgående analyse
15-11-2012
Disease mongering is the promotion of pseudo-diseases by the pharmaceutical industry aiming at economic benefit. Medical equipment manufacturers, insurance companies, doctors or patient groups may also use it for monetary gain or influence. It has increased in parallel with society's 'medicalisation' and the growth of the pharmaceutical complex. Due to massive investments in marketing and lobbying, ample use of internet and media, and the emergence of new markets, it is becoming a matter of concern, and policy makers should be aware of its perils and consequences.
Indgående analyse
Om dette dokument
Type af publikation
Politikområde
Nøgleord
- ARBEJDE OG BESKÆFTIGELSE
- arbejdsmarkedsrelationer og arbejdsret
- DEN EUROPÆISKE UNION
- Det Europæiske Lægemiddelagentur
- EU-institutioner og EU-forvaltning
- farmaceutisk produkt
- forbrug
- forbrugerbeskyttelse
- interessekonflikt
- medicinalindustri
- offentlig sundhed
- SOCIALE SPØRGSMÅL
- sundhed
- sundhedstjeneste
- sygdomsforebyggelse
- ØKONOMISK OG HANDELSMÆSSIGT SAMKVEM